Page last updated: 2024-08-23

azoxymethane and sulindac sulfide

azoxymethane has been researched along with sulindac sulfide in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kawamori, T; Kelloff, GJ; Lubet, RA; Rao, CV; Reddy, BS; Steele, VE	1
Koetsier, JL; Kunte, DP; Roy, HK; Wali, RK	1

Other Studies

2 other study(ies) available for azoxymethane and sulindac sulfide

Article	Year
Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process. Cancer research, 1999, Jul-15, Volume: 59, Issue:14 Topics: Adenocarcinoma; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Azoxymethane; Carcinogens; Cell Transformation, Neoplastic; Colonic Neoplasms; Cyclooxygenase Inhibitors; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; Neoplasm Invasiveness; Rats; Rats, Inbred F344; Sulindac; Weight Gain	1999
Antiproliferative effect of sulindac in colonic neoplasia prevention: role of COOH-terminal Src kinase. Molecular cancer therapeutics, 2008, Volume: 7, Issue:7 Topics: Animals; Antineoplastic Agents; Azoxymethane; Cell Cycle; Cell Proliferation; Colon; Colonic Neoplasms; CSK Tyrosine-Protein Kinase; Cyclin-Dependent Kinase Inhibitor p21; Down-Regulation; Drug Screening Assays, Antitumor; Enzyme Induction; HT29 Cells; Humans; Male; Models, Biological; Protein-Tyrosine Kinases; Rats; Rats, Inbred F344; src-Family Kinases; Sulindac	2008

Article

Year

Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process.

Cancer research, 1999, Jul-15, Volume: 59, Issue:14

Topics: Adenocarcinoma; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Azoxymethane; Carcinogens; Cell Transformation, Neoplastic; Colonic Neoplasms; Cyclooxygenase Inhibitors; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; Neoplasm Invasiveness; Rats; Rats, Inbred F344; Sulindac; Weight Gain

1999

Antiproliferative effect of sulindac in colonic neoplasia prevention: role of COOH-terminal Src kinase.

Molecular cancer therapeutics, 2008, Volume: 7, Issue:7

Topics: Animals; Antineoplastic Agents; Azoxymethane; Cell Cycle; Cell Proliferation; Colon; Colonic Neoplasms; CSK Tyrosine-Protein Kinase; Cyclin-Dependent Kinase Inhibitor p21; Down-Regulation; Drug Screening Assays, Antitumor; Enzyme Induction; HT29 Cells; Humans; Male; Models, Biological; Protein-Tyrosine Kinases; Rats; Rats, Inbred F344; src-Family Kinases; Sulindac

2008